Reference number : 236-2018-2019-Q1-00275, amendment number : , agreement type : G, recipient legal name : Dierick, France J, recipient country : CA, recipient province : QC, recipient city : Montreal, recipient postal code : H3T 1E2, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 870.0, agreement start date : 2018-04-01, agreement end date : 2019-03-31, description english : PDGF Receptor alpha inhibition prevents high blood flow-induced atherosclerotic plaque regression, description french : PDGF Receptor alpha inhibition prevents high blood flow-induced atherosclerotic plaque regression, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada